




Searching News Database: BD
HSMN NewsFeed - 17 Dec 2024
BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations
BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations
HSMN NewsFeed - 25 Jul 2024
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
HSMN NewsFeed - 8 Jul 2024
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
HSMN NewsFeed - 7 Dec 2023
BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
HSMN NewsFeed - 30 Nov 2023
BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency
BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency
HSMN NewsFeed - 1 Aug 2023
BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
HSMN NewsFeed - 24 Jul 2023
BD CEO Tom Polen Addresses FDA 510(k) Clearance of BD Alaris(TM) Infusion System
BD CEO Tom Polen Addresses FDA 510(k) Clearance of BD Alaris(TM) Infusion System
HSMN NewsFeed - 16 May 2023
BD Gains 510(k) Clearance of Artificial Intelligence Software for MRSA Diagnostics
BD Gains 510(k) Clearance of Artificial Intelligence Software for MRSA Diagnostics
HSMN NewsFeed - 15 Mar 2023
Medtronic receives CE Mark approval for Affera(TM) Mapping and Ablation System to treat atrial arrhythmias
Medtronic receives CE Mark approval for Affera(TM) Mapping and Ablation System to treat atrial arrhythmias
HSMN NewsFeed - 13 Sep 2022
BD Launches Next Generation Prefillable Vaccine Syringe Designed for Reliability, Efficiency
BD Launches Next Generation Prefillable Vaccine Syringe Designed for Reliability, Efficiency
HSMN NewsFeed - 30 Jun 2022
BD Launches Combination Test for COVID-19, Influenza A/B and Respiratory Syncytial Virus
BD Launches Combination Test for COVID-19, Influenza A/B and Respiratory Syncytial Virus
HSMN NewsFeed - 12 May 2022
BD Launches Fully Automated, High-Throughput Infectious Disease Molecular Diagnostic Platform in the U.S.
BD Launches Fully Automated, High-Throughput Infectious Disease Molecular Diagnostic Platform in the U.S.
HSMN NewsFeed - 25 Apr 2022
New BD Reagents Enable Researchers to Break Through Resolution Boundaries in Flow Cytometry
New BD Reagents Enable Researchers to Break Through Resolution Boundaries in Flow Cytometry
HSMN NewsFeed - 9 Mar 2022
Orna Therapeutics Bolsters Leadership Team with Key Executive and Board Appointments
Orna Therapeutics Bolsters Leadership Team with Key Executive and Board Appointments
HSMN NewsFeed - 17 Dec 2021
BD Expands Fully Automated High-Throughput Molecular Diagnostic Platform for Core Labs
BD Expands Fully Automated High-Throughput Molecular Diagnostic Platform for Core Labs
HSMN NewsFeed - 9 Dec 2021
BD Acquires Tissuemed, Ltd. to Add Advanced Sealant to its Portfolio of Surgical Solutions
BD Acquires Tissuemed, Ltd. to Add Advanced Sealant to its Portfolio of Surgical Solutions
HSMN NewsFeed - 2 Dec 2021
BD Acquires Venclose, Inc. To Extend Treatment Innovations In Chronic Venous Disease
BD Acquires Venclose, Inc. To Extend Treatment Innovations In Chronic Venous Disease
HSMN NewsFeed - 24 Nov 2021
BD Names Francesca DeMartino as Senior Vice President of Investor Relations
BD Names Francesca DeMartino as Senior Vice President of Investor Relations
HSMN NewsFeed - 26 Oct 2021
BD Begins Shipments Of First Smartphone Interpreted Over-The-Counter Rapid COVID-19 Test
BD Begins Shipments Of First Smartphone Interpreted Over-The-Counter Rapid COVID-19 Test
HSMN NewsFeed - 6 Oct 2021
BD Announces 510(k) Clearance of Expanded Indications for the Rotarex(TM) Atherectomy System
BD Announces 510(k) Clearance of Expanded Indications for the Rotarex(TM) Atherectomy System
HSMN NewsFeed - 25 Aug 2021
BD Launches Fully Automated High-Throughput Molecular Diagnostic Platform for U.S. Laboratories
BD Launches Fully Automated High-Throughput Molecular Diagnostic Platform for U.S. Laboratories
HSMN NewsFeed - 27 Jul 2021
BD Acquires Tepha, Inc., to Drive New Innovations in Soft Tissue Repair and Regeneration
BD Acquires Tepha, Inc., to Drive New Innovations in Soft Tissue Repair and Regeneration
HSMN NewsFeed - 25 May 2021
BD Launches Industry First Ready-to-Use Iodine-Based Surgical Irrigation System
BD Launches Industry First Ready-to-Use Iodine-Based Surgical Irrigation System
HSMN NewsFeed - 29 Apr 2021
BD Announces Enrollment in Post-Market Studies of the WavelinQ(TM) Arteriovenous Endovascular Fistula
BD Announces Enrollment in Post-Market Studies of the WavelinQ(TM) Arteriovenous Endovascular Fistula
HSMN NewsFeed - 15 Apr 2021
Vicarious Surgical Inc. and D8 Holdings Corp. Announce Definitive Business Combination Agreement
Vicarious Surgical Inc. and D8 Holdings Corp. Announce Definitive Business Combination Agreement
HSMN NewsFeed - 10 Mar 2021
Novum Medical(TM) Appoints Tom Afzal as CEO and Announces Closing of Financing
Novum Medical(TM) Appoints Tom Afzal as CEO and Announces Closing of Financing
HSMN NewsFeed - 15 Feb 2021
Avexegen Therapeutics Receives a $2.94M NIH Grant to Advance Treatment for Inflammatory Bowel Disease
Avexegen Therapeutics Receives a $2.94M NIH Grant to Advance Treatment for Inflammatory Bowel Disease
HSMN NewsFeed - 30 Sep 2020
BD Announces CE Mark of Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes
BD Announces CE Mark of Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes
HSMN NewsFeed - 22 Jul 2020
BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities
BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities
HSMN NewsFeed - 7 Jul 2020
BD Launches First and Only Fully Sterile Povidone-Iodine and Isopropyl Alcohol Skin Preparation
BD Launches First and Only Fully Sterile Povidone-Iodine and Isopropyl Alcohol Skin Preparation
HSMN NewsFeed - 3 Apr 2020
BD, BioGX Announce FDA Emergency Use Authorization for New COVID-19 Diagnostic for Use in U.S.
BD, BioGX Announce FDA Emergency Use Authorization for New COVID-19 Diagnostic for Use in U.S.
HSMN NewsFeed - 14 Mar 2019
BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease
BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease
HSMN NewsFeed - 24 Jan 2019
BD Launches Ergonomic Pen Needle Technology to Help Optimize Injection Technique
BD Launches Ergonomic Pen Needle Technology to Help Optimize Injection Technique
HSMN NewsFeed - 29 Nov 2018
BD Expands Integrated Medication Management to Help Tackle Hospital Drug Diversion
BD Expands Integrated Medication Management to Help Tackle Hospital Drug Diversion
HSMN NewsFeed - 24 Oct 2018
Inova Diagnostics Launches First FDA Cleared Calprotectin Extraction Device
Inova Diagnostics Launches First FDA Cleared Calprotectin Extraction Device
HSMN NewsFeed - 23 Oct 2018
BioGX Launches 5 new CE Mark IVD Tests, Expands Sexual Health Panels on the BD MAX(TM)
BioGX Launches 5 new CE Mark IVD Tests, Expands Sexual Health Panels on the BD MAX(TM)
HSMN NewsFeed - 7 Sep 2018
Thermo Fisher Scientific to Acquire Advanced Bioprocessing Business from BD
Thermo Fisher Scientific to Acquire Advanced Bioprocessing Business from BD
HSMN NewsFeed - 9 Jul 2018
BD Acquires TVA Medical to Advance Leadership in Solutions for Chronic Kidney Disease
BD Acquires TVA Medical to Advance Leadership in Solutions for Chronic Kidney Disease
HSMN NewsFeed - 24 May 2018
BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance
BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance
HSMN NewsFeed - 18 May 2018
FDA Approves Aimovig(TM) (erenumab-aooe), A Novel Treatment Developed Specifically For Migraine Prevention
FDA Approves Aimovig(TM) (erenumab-aooe), A Novel Treatment Developed Specifically For Migraine Prevention
HSMN NewsFeed - 27 Apr 2018
Hill-Rom Appoints John Groetelaars As President And Chief Executive Officer
Hill-Rom Appoints John Groetelaars As President And Chief Executive Officer
HSMN NewsFeed - 20 Feb 2018
Peritech Pharma's Novel Hemorrhoids Treatment Commercialized in 24 Countries
Peritech Pharma's Novel Hemorrhoids Treatment Commercialized in 24 Countries
HSMN NewsFeed - 15 Jan 2018
BD and Check-Points Receive CE Mark for Next-generation Resistant Bacteria Screening Test
BD and Check-Points Receive CE Mark for Next-generation Resistant Bacteria Screening Test
HSMN NewsFeed - 12 Jan 2018
BD Statement on FDA Warning Letter for Preanalytical Systems Business Unit
BD Statement on FDA Warning Letter for Preanalytical Systems Business Unit
HSMN NewsFeed - 3 Jan 2018
Inova Diagnostics Receives FDA Clearance for the First Fully Automated, Random Access Calprotectin Test
Inova Diagnostics Receives FDA Clearance for the First Fully Automated, Random Access Calprotectin Test
HSMN NewsFeed - 16 Nov 2017
BD Statement On Merit Medical Agreement To Purchase BD, Bard Product Lines
BD Statement On Merit Medical Agreement To Purchase BD, Bard Product Lines
HSMN NewsFeed - 20 Jun 2017
BD Receives FDA 510(k) Clearance for New Line of Customizable, 3.0mm Micro-Laparoscopic Instruments
BD Receives FDA 510(k) Clearance for New Line of Customizable, 3.0mm Micro-Laparoscopic Instruments
HSMN NewsFeed - 9 May 2017
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
HSMN NewsFeed - 22 Feb 2017
BD Veritor(TM) System Meets FDA's New Performance Requirements for Rapid Influenza Antigen Detection Tests
BD Veritor(TM) System Meets FDA's New Performance Requirements for Rapid Influenza Antigen Detection Tests
HSMN NewsFeed - 8 Nov 2016
BD Launches First Syringe Designed for Use with Humulin(R) R U-500 Insulin
BD Launches First Syringe Designed for Use with Humulin(R) R U-500 Insulin
HSMN NewsFeed - 6 Sep 2016
BD Submits Pre-Market Approval Application to FDA for BD Onclarity(TM) HPV Test
BD Submits Pre-Market Approval Application to FDA for BD Onclarity(TM) HPV Test
HSMN NewsFeed - 11 Apr 2016
GW Pharmaceuticals Initiates Phase 3 Pivotal Study in Tuberous Sclerosis Complex
GW Pharmaceuticals Initiates Phase 3 Pivotal Study in Tuberous Sclerosis Complex
HSMN NewsFeed - 26 Oct 2015
CareFusion Signs Exclusive Distribution Agreement With AAM Healthcare For Video Laryngoscope
CareFusion Signs Exclusive Distribution Agreement With AAM Healthcare For Video Laryngoscope
HSMN NewsFeed - 10 Sep 2015
Protagonist Therapeutics Names Richard S. Shames, M.D. as Chief Medical Officer
Protagonist Therapeutics Names Richard S. Shames, M.D. as Chief Medical Officer
HSMN NewsFeed - 6 Aug 2014
BD AutoShield(TM) Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes
BD AutoShield(TM) Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes
HSMN NewsFeed - 28 Jul 2014
New Chlamydia and Gonorrhea Assays on the BD Viper(TM) LT System Receive FDA 510k Clearance
New Chlamydia and Gonorrhea Assays on the BD Viper(TM) LT System Receive FDA 510k Clearance
HSMN NewsFeed - 28 Apr 2014
GW Pharmaceuticals Announces That Sativex Receives Fast Track Designation From FDA in Cancer Pain
GW Pharmaceuticals Announces That Sativex Receives Fast Track Designation From FDA in Cancer Pain
HSMN NewsFeed - 7 Feb 2014
Leading Industry Analyst Amit Bhalla Joins BD as Vice President, Global Strategy and Development
Leading Industry Analyst Amit Bhalla Joins BD as Vice President, Global Strategy and Development
HSMN NewsFeed - 4 Nov 2013
Samsung Announces US Commercial Release of Samsung XGEO GC80 Digital Radiography System
Samsung Announces US Commercial Release of Samsung XGEO GC80 Digital Radiography System
HSMN NewsFeed - 7 May 2013
Coronado Biosciences Appoints Thomas F. Schaible, Ph.D. as Project Leader, Inflammatory Bowel Disease
Coronado Biosciences Appoints Thomas F. Schaible, Ph.D. as Project Leader, Inflammatory Bowel Disease
HSMN NewsFeed - 23 Apr 2013
FDA Approves Second Drug in BD Simplist(TM) Prefilled Injectable Line of Products
FDA Approves Second Drug in BD Simplist(TM) Prefilled Injectable Line of Products
HSMN NewsFeed - 11 Apr 2013
BD Announces FDA 510(k) Clearance and Commercial Launch of BD UltraSafe PLUS(TM) Passive Needle Guard
BD Announces FDA 510(k) Clearance and Commercial Launch of BD UltraSafe PLUS(TM) Passive Needle Guard
HSMN NewsFeed - 27 Mar 2013
BD Enters Pharmaceutical Industry with New Line of Generic Prefilled Injectable Products
BD Enters Pharmaceutical Industry with New Line of Generic Prefilled Injectable Products
HSMN NewsFeed - 21 Mar 2013
Results of Lymphoseek(R) Phase 3 Clinical Trials in Breast Cancer Published in Annals of Surgical Oncology
Results of Lymphoseek(R) Phase 3 Clinical Trials in Breast Cancer Published in Annals of Surgical Oncology
HSMN NewsFeed - 9 Oct 2012
Integra LifeSciences Receives FDA Clearance for Expanded Indication for Spinal Device
Integra LifeSciences Receives FDA Clearance for Expanded Indication for Spinal Device
HSMN NewsFeed - 31 Jul 2012
Prometheus Launches New Monitoring Test To Help Guide Inflammatory Bowel Disease Management
Prometheus Launches New Monitoring Test To Help Guide Inflammatory Bowel Disease Management
HSMN NewsFeed - 2 Nov 2011
Integra LifeSciences Launches a Zero-Profile, Stand-Alone Interbody Device for Neck Surgery
Integra LifeSciences Launches a Zero-Profile, Stand-Alone Interbody Device for Neck Surgery
HSMN NewsFeed - 3 Oct 2011
Integra LifeSciences Meets Surgeon Demand for User-Friendly Minimally Invasive Spinal Solutions
Integra LifeSciences Meets Surgeon Demand for User-Friendly Minimally Invasive Spinal Solutions
HSMN NewsFeed - 11 Apr 2011
Integra LifeSciences Receives FDA Approvals for Three Spinal Fixation Devices
Integra LifeSciences Receives FDA Approvals for Three Spinal Fixation Devices
HSMN NewsFeed - 2 Aug 2010
BD Completes Sales of Ophthalmic Systems Unit and Surgical Blades Product Platform
BD Completes Sales of Ophthalmic Systems Unit and Surgical Blades Product Platform
HSMN NewsFeed - 29 Jul 2010
BD Announces Appointment of Zachary A. Nagle as Vice President, Investor Relations
BD Announces Appointment of Zachary A. Nagle as Vice President, Investor Relations
HSMN NewsFeed - 29 Jul 2010
BD Announces Promotion of President Vince Forlenza; Gains Additional Title of Chief Operating Officer
BD Announces Promotion of President Vince Forlenza; Gains Additional Title of Chief Operating Officer
HSMN NewsFeed - 12 May 2010
Terumo To Simultaneously Evaluate Misago Self-Expanding Stent System in the United States and Japan
Terumo To Simultaneously Evaluate Misago Self-Expanding Stent System in the United States and Japan
HSMN NewsFeed - 7 Oct 2009
Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today
Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today
HSMN NewsFeed - 17 Mar 2009
HyperBranch Medical Technology, Inc. Licenses OcuSeal Liquid Ocular Bandage to BD
HyperBranch Medical Technology, Inc. Licenses OcuSeal Liquid Ocular Bandage to BD
HSMN NewsFeed - 12 Jan 2009
BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
HSMN NewsFeed - 9 Jan 2009
Integra LifeSciences Launches a Series of PEEK-Optima(R) Interbody Spinal Implants
Integra LifeSciences Launches a Series of PEEK-Optima(R) Interbody Spinal Implants
HSMN NewsFeed - 11 Dec 2008
New Data Shows Zometa(R) Enhances Impact of Chemotherapy on Reducing Breast Tumour Size
New Data Shows Zometa(R) Enhances Impact of Chemotherapy on Reducing Breast Tumour Size
HSMN NewsFeed - 10 Dec 2008
MorphoSys Appoints Dr. Arndt Schottelius as Chief Development Officer and Member of the Management Board
MorphoSys Appoints Dr. Arndt Schottelius as Chief Development Officer and Member of the Management Board
HSMN NewsFeed - 26 Nov 2008
MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease
MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease
HSMN NewsFeed - 5 Nov 2008
BD Announces Executive Appointments of President and Chief Financial Officer
BD Announces Executive Appointments of President and Chief Financial Officer
HSMN NewsFeed - 21 Oct 2008
New Multicenter Study Underscores Value of Using PillCam(R) SB in Children Younger Than 8
New Multicenter Study Underscores Value of Using PillCam(R) SB in Children Younger Than 8
HSMN NewsFeed - 26 Aug 2008
BD (Becton, Dickinson and Company) Licenses Intellectual Property to Ivera Medical Corporation
BD (Becton, Dickinson and Company) Licenses Intellectual Property to Ivera Medical Corporation
HSMN NewsFeed - 1 Jul 2008
Synthetic Blood International Changes Name to Oxygen Biotherapeutics, Inc.
Synthetic Blood International Changes Name to Oxygen Biotherapeutics, Inc.
HSMN NewsFeed - 30 Jun 2008
William D. Schwieterman, M.D. Joins Chelsea Therapeutics' Board of Directors
William D. Schwieterman, M.D. Joins Chelsea Therapeutics' Board of Directors
HSMN NewsFeed - 16 Jun 2008
OncoMed Pharmaceuticals Extends License Agreement for Use of MorphoSys's Core Technology
OncoMed Pharmaceuticals Extends License Agreement for Use of MorphoSys's Core Technology
HSMN NewsFeed - 2 Jun 2008
Adolor Promotes Dr. Lee Techner to Vice President, Medical Affairs and Medical Director
Adolor Promotes Dr. Lee Techner to Vice President, Medical Affairs and Medical Director
HSMN NewsFeed - 20 May 2008
Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients
Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients
HSMN NewsFeed - 22 Apr 2008
Synthetic Blood International, Inc. to Seek Shareholder Approval for Name Change
Synthetic Blood International, Inc. to Seek Shareholder Approval for Name Change
HSMN NewsFeed - 10 Apr 2008
Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
HSMN NewsFeed - 31 Mar 2008
Synthetic Blood International, Inc. Announces New Leadership Roles to Continue Product Development Strategy
Synthetic Blood International, Inc. Announces New Leadership Roles to Continue Product Development Strategy
HSMN NewsFeed - 24 Mar 2008
Synthetic Blood International, Inc. Announces Passing of Interim CEO Robert Larsen
Synthetic Blood International, Inc. Announces Passing of Interim CEO Robert Larsen
HSMN NewsFeed - 18 Mar 2008
BD Board of Directors Elects John R. Considine as Vice Chairman and Member of the Board of Directors
BD Board of Directors Elects John R. Considine as Vice Chairman and Member of the Board of Directors
HSMN NewsFeed - 18 Mar 2008
Titan Spine's ENDOSKELETON(R) TA Passes Test In Competitive Lower Back Pain Market
Titan Spine's ENDOSKELETON(R) TA Passes Test In Competitive Lower Back Pain Market
HSMN NewsFeed - 10 Mar 2008
Symbollon Pharmaceuticals Signs Term Sheet to Acquire Chinese Pharmaceutical Company
Symbollon Pharmaceuticals Signs Term Sheet to Acquire Chinese Pharmaceutical Company
HSMN NewsFeed - 26 Feb 2008
Synthetic Blood Announces Department of Defense Grant for Traumatic Brain Injury Clinical Trial with Oxycyte
Synthetic Blood Announces Department of Defense Grant for Traumatic Brain Injury Clinical Trial with Oxycyte
HSMN NewsFeed - 8 Feb 2008
Synthetic Blood Announces Medical Advisory Board Meeting Results, New Additions to Board
Synthetic Blood Announces Medical Advisory Board Meeting Results, New Additions to Board
HSMN NewsFeed - 11 Dec 2007
Synthetic Blood Announces Progress with Oxycyte Program in Traumatic Brain Injury
Synthetic Blood Announces Progress with Oxycyte Program in Traumatic Brain Injury
HSMN NewsFeed - 15 Nov 2007
Intranasal Therapeutics, Inc. Names Vice Presidents of Pharmaceutical Development and Commercial Development
Intranasal Therapeutics, Inc. Names Vice Presidents of Pharmaceutical Development and Commercial Development
HSMN NewsFeed - 14 Nov 2007
Aspen Technology Appoints James Hintlian to Launch Pharmaceuticals Business Unit
Aspen Technology Appoints James Hintlian to Launch Pharmaceuticals Business Unit
HSMN NewsFeed - 12 Nov 2007
FDA Accepts Chelsea Therapeutics' Investigational New Drug Application for Droxidopa
FDA Accepts Chelsea Therapeutics' Investigational New Drug Application for Droxidopa
HSMN NewsFeed - 15 Oct 2007
Avery Biomedical Devices, Inc. Appoints Elefteriades to its Board of Directors
Avery Biomedical Devices, Inc. Appoints Elefteriades to its Board of Directors
HSMN NewsFeed - 4 Oct 2007
New Contracted Supplier Added to Premier's New Safety IV Catheter Agreements
New Contracted Supplier Added to Premier's New Safety IV Catheter Agreements
HSMN NewsFeed - 24 Sep 2007
Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
HSMN NewsFeed - 20 Sep 2007
Hospitals, Healthcare Providers to Save With Premier's Safety IV Catheter Agreements
Hospitals, Healthcare Providers to Save With Premier's Safety IV Catheter Agreements
HSMN NewsFeed - 13 Sep 2007
FDA To Continue Its Review of Requests for Release of Clinical Hold on alvimopan (Entereg(R))
FDA To Continue Its Review of Requests for Release of Clinical Hold on alvimopan (Entereg(R))
HSMN NewsFeed - 28 Aug 2007
FDA Accepts for Review Complete Response to Approvable Letter for Entereg(R) (alvimopan) for POI
FDA Accepts for Review Complete Response to Approvable Letter for Entereg(R) (alvimopan) for POI
HSMN NewsFeed - 14 Aug 2007
European Commission Grants Chelsea Therapeutics Two Orphan Medicinal Product Designations for Droxidopa
European Commission Grants Chelsea Therapeutics Two Orphan Medicinal Product Designations for Droxidopa
HSMN NewsFeed - 7 Aug 2007
BD Taps Seasoned Executive and Researcher to Serve as Company's Chief Technology Officer
BD Taps Seasoned Executive and Researcher to Serve as Company's Chief Technology Officer
HSMN NewsFeed - 29 Jun 2007
Bayer HealthCare Announces New 2000 IU Vial Size for Kogenate(R) FS Treatments
Bayer HealthCare Announces New 2000 IU Vial Size for Kogenate(R) FS Treatments
HSMN NewsFeed - 11 Jun 2007
GSK and Adolor Update Alvimopan (Entereg/Entrareg(R)) Development Program
GSK and Adolor Update Alvimopan (Entereg/Entrareg(R)) Development Program
HSMN NewsFeed - 15 May 2007
Ciphergen Appoints Steve Lundy as Senior Vice President of Sales and Marketing
Ciphergen Appoints Steve Lundy as Senior Vice President of Sales and Marketing
HSMN NewsFeed - 9 Apr 2007
GSK and Adolor Announce Preliminary Results from Phase 3 Safety Study of Alvimopan (ENTEREG/ENTRAREG(R))
GSK and Adolor Announce Preliminary Results from Phase 3 Safety Study of Alvimopan (ENTEREG/ENTRAREG(R))
HSMN NewsFeed - 8 Mar 2007
Siemens Completes Acquisition of the BD.id(TM) System for Patient Identification and Specimen Management
Siemens Completes Acquisition of the BD.id(TM) System for Patient Identification and Specimen Management
HSMN NewsFeed - 20 Feb 2007
Shire Agrees to Acquire New River to Gain Full Control of VYVANSE(TM), its Future Flagship Product for ADHD
Shire Agrees to Acquire New River to Gain Full Control of VYVANSE(TM), its Future Flagship Product for ADHD
HSMN NewsFeed - 22 Dec 2006
Synthetic Blood Reports Positive Preliminary Results From Traumatic Brain Injury Clinical Trial
Synthetic Blood Reports Positive Preliminary Results From Traumatic Brain Injury Clinical Trial
HSMN NewsFeed - 19 Dec 2006
TriPath Imaging Stockholders Approve Merger With Becton, Dickinson and Company
TriPath Imaging Stockholders Approve Merger With Becton, Dickinson and Company
HSMN NewsFeed - 2 Oct 2006
Alert for BD Logic(R) Meter Users: Roche Diagnostics Offers ACCU-CHEK(R) Blood Glucose Systems
Alert for BD Logic(R) Meter Users: Roche Diagnostics Offers ACCU-CHEK(R) Blood Glucose Systems
HSMN NewsFeed - 29 Sep 2006
Abbott to Provide a Free Blood Glucose Monitoring System to All Becton, Dickinson BD Logic(R) Patients
Abbott to Provide a Free Blood Glucose Monitoring System to All Becton, Dickinson BD Logic(R) Patients
HSMN NewsFeed - 5 Jul 2006
Cardinal Health Aligns Manufacturing Businesses, Names International President
Cardinal Health Aligns Manufacturing Businesses, Names International President
HSMN NewsFeed - 28 Jun 2006
Adolor Corporation Appoints Scott T. Megaffin as Vice President, Marketing
Adolor Corporation Appoints Scott T. Megaffin as Vice President, Marketing
HSMN NewsFeed - 31 May 2006
SHPI Enters OEM Supply Agreement with ICU Medical for SecureLoc(TM) Safety Introducer Needle
SHPI Enters OEM Supply Agreement with ICU Medical for SecureLoc(TM) Safety Introducer Needle
HSMN NewsFeed - 31 May 2006
Adolor's Complete Response to Approvable Letter for Entereg(R) (Alvimopan) in POI Accepted for Review by FDA
Adolor's Complete Response to Approvable Letter for Entereg(R) (Alvimopan) in POI Accepted for Review by FDA
Additional items found! 99

Members Archive contains
99 additional stories matching:
BD
(Password required)
BD
(Password required)